EUVIMEDEUVIMED entdecken
Open Access

Metabolic and other morbid complications in congenital generalized lipodystrophy type 4

Gulcin Akinci, Saif Alyaarubi, Nivedita Patni, Nadia Alhashmi, Azza Al-Shidhani, Flavia Prodam, Nancy Gagne, Funmbi Babalola, Aisha Al Senani, Kavitha Muniraj, Solaf M Elsayed, Marianna Beghini und 26 weitere

American Journal of Medical Genetics Part A · 2024-06 · 194 (6)

DOI: 10.1002/ajmg.a.63533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 17.01.2024. Verfasst von Gulcin Akinci und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, University of Health Sciences, Izmir Faculty of Medicine, Behcet Uz Children's Hospital, Izmir, Turkey. Hauptthemen laut MEDLINE: Lipodystrophy, Congenital Generalized, RNA-Binding Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Morbidity and mortality rates in patients with autosomal recessive, congenital generalized lipodystrophy type 4 (CGL4), an ultra‐rare disorder, remain unclear. We report on 30 females and 16 males from 10 countries with biallelic null variants in CAVIN1 gene (mean age, 12 years; range, 2 months to 41 years). Hypertriglyceridemia was seen in 79% (34/43), hepatic steatosis in 82% (27/33) but diabetes mellitus in only 21% (8/44). Myopathy with elevated serum creatine kinase levels (346–3325 IU/L) affected all of them (38/38). 39% had scoliosis (10/26) and 57% had atlantoaxial instability (8/14). Cardiac arrhythmias were detected in 57% (20/35) and 46% had ventricular tachycardia (16/35). Congenital pyloric stenosis was diagnosed in 39% (18/46), 9 had esophageal dysmotility and 19 had intestinal dysmotility. Four patients suffered from intestinal perforations. Seven patients died at mean age of 17 years (range: 2 months to 39 years). The cause of death in four patients was cardiac arrhythmia and sudden death, while others died of prematurity, gastrointestinal perforation, and infected foot ulcers leading to sepsis. Our study highlights high prevalence of myopathy, metabolic abnormalities, cardiac, and gastrointestinal problems in patients with CGL4. CGL4 patients are at high risk of early death mainly caused by cardiac arrhythmias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipodystrophy, Congenital GeneralizedRNA-Binding ProteinsHumansMaleFemaleAdolescentChildInfantChild, PreschoolAdultYoung AdultArrhythmias, CardiacHypertriglyceridemia

Stichwörter der Autor:innen

CAVIN1congenital generalized lipodystrophygastrointestinal diseasemetabolic abnormalitiesmyopathyventricular tachycardia

Substanzen

CAVIN1 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pediatric Neurology, University of Health Sciences, Izmir Faculty of Medicine, Behcet Uz Children's Hospital, Izmir, Turkey.
  • Oman Medical Specialty Board, Muscat, Oman.
  • Division of Pediatric Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Clinical and Biochemical Genetics Department, Child Health Department, Royal Hospital, Muscat, Oman.
  • Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
  • Department of Pediatrics, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.

ORCID-Profile: Baris Akinci, Abhimanyu Garg

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Southwestern Medical Foundation

Zitieren

APA

Akinci, G., Alyaarubi, S., Patni, N., Alhashmi, N., Al-Shidhani, A., Prodam, F., Gagne, N., Babalola, F., Al Senani, A., Muniraj, K., Elsayed, S. M., Beghini, M., Saydam, B. O., Allawati, M., Vaishnav, M. S., Can, E., Simsir, I. Y., Sorkina, E., Dursun, F., …, & Garg, A. (2024). Metabolic and other morbid complications in congenital generalized lipodystrophy type 4. American Journal of Medical Genetics Part A, 194(6). https://doi.org/10.1002/ajmg.a.63533

Vancouver

Akinci G, Alyaarubi S, Patni N, Alhashmi N, Al-Shidhani A, Prodam F, et al. Metabolic and other morbid complications in congenital generalized lipodystrophy type 4. American Journal of Medical Genetics Part A. 2024;194(6). doi:10.1002/ajmg.a.63533

BibTeX
@article{Akinci2024,
  author = {Akinci, Gulcin and Alyaarubi, Saif and Patni, Nivedita and Alhashmi, Nadia and Al-Shidhani, Azza and Prodam, Flavia and Gagne, Nancy and Babalola, Funmbi and Al Senani, Aisha and Muniraj, Kavitha and Elsayed, Solaf M and Beghini, Marianna and Saydam, Basak Ozgen and Allawati, Moosa and Vaishnav, Madhumati S and Can, Ender and Simsir, Ilgin Y and Sorkina, Ekaterina and Dursun, Fatma and Kamrath, Clemens and Cavdar, Umit and Chakraborty, Partha P and Dogan, Ozlem Akgun and Al Hosin, Aliya and Al Maimani, Ashwaq and Comunoglu, Nil and Hamed, Ahmed and Huseinbegovic, Tea and Scherer, Thomas and Curtis, Jacqueline and Brown, Rebecca J and Topaloglu, Haluk and Simha, Vinaya and Wabitsch, Martin and Tuysuz, Beyhan and Oral, Elif A and Akinci, Baris and Garg, Abhimanyu},
  title = {Metabolic and other morbid complications in congenital generalized lipodystrophy type 4},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  volume = {194},
  number = {6},
  doi = {10.1002/ajmg.a.63533}
}
Kostenlos starten →